Literature DB >> 23135544

LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE.

Angel Ashikov1, Falk F R Buettner, Birgit Tiemann, Rita Gerardy-Schahn, Hans Bakker.   

Abstract

LARGE (like-glycosyltransferase) and LARGE2 (glycosyltransferase-like 1B (GYLTL1B)) are homologous Golgi glycosyltransferases possessing two catalytic domains with homology to members of glycosyltransferase families GT8 and GT49. Mutations in human and mouse Large result in muscular dystrophy due to underglycosylation of dystroglycan. The systemic function of LARGE2 is unknown, but at a cellular level the enzyme can substitute for LARGE in glycosylating dystroglycan. Here, we show that LARGE2 catalyzes the same glycosylation reaction as LARGE. It is a bifunctional glycosyltransferase using uridine diphosphate (UDP)-xylose (Xyl) and UDP-glucuronic acid (GlcA) as donor sugars to produce a xyloglucuronan with alternating Xyl and GlcA residues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135544     DOI: 10.1093/glycob/cws153

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  13 in total

Review 1.  Recent advancements in understanding mammalian O-mannosylation.

Authors:  M Osman Sheikh; Stephanie M Halmo; Lance Wells
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

2.  Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.

Authors:  Kei-ichiro Inamori; Tobias Willer; Yuji Hara; David Venzke; Mary E Anderson; Nigel F Clarke; Pascale Guicheney; Carsten G Bönnemann; Steven A Moore; Kevin P Campbell
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

3.  Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.

Authors:  M Osman Sheikh; Chantelle J Capicciotti; Lin Liu; Jeremy Praissman; Dahai Ding; Daniel G Mead; Melinda A Brindley; Tobias Willer; Kevin P Campbell; Kelley W Moremen; Lance Wells; Geert-Jan Boons
Journal:  Nat Commun       Date:  2022-06-24       Impact factor: 17.694

Review 4.  Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Authors:  Takako Yoshida-Moriguchi; Kevin P Campbell
Journal:  Glycobiology       Date:  2015-04-16       Impact factor: 4.313

Review 5.  Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.

Authors:  Jeremy L Praissman; Lance Wells
Journal:  Biochemistry       Date:  2014-05-07       Impact factor: 3.162

6.  The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.

Authors:  Tobias Willer; Kei-Ichiro Inamori; David Venzke; Corinne Harvey; Greg Morgensen; Yuji Hara; Daniel Beltrán Valero de Bernabé; Liping Yu; Kevin M Wright; Kevin P Campbell
Journal:  Elife       Date:  2014-10-03       Impact factor: 8.140

7.  LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.

Authors:  Kei-Ichiro Inamori; Aaron M Beedle; Daniel Beltrán-Valero de Bernabé; Michael E Wright; Kevin P Campbell
Journal:  Glycobiology       Date:  2016-07-22       Impact factor: 4.313

8.  Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy.

Authors:  Helen S Booler; Josie L Williams; Mark Hopkinson; Susan C Brown
Journal:  Brain Pathol       Date:  2015-10-12       Impact factor: 6.508

9.  A Method to Produce and Purify Full-Length Recombinant Alpha Dystroglycan: Analysis of N- and O-Linked Monosaccharide Composition in CHO Cells with or without LARGE Overexpression.

Authors:  Jung Hae Yoon; Rui Xu; Paul Martin
Journal:  PLoS Curr       Date:  2013-01-02

10.  Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice.

Authors:  Anthony Blaeser; Hiroyuki Awano; Bo Wu; Qi-Long Lu
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.